Requirement for vitamin D supplementation in patients using photoprotection: Variations in vitamin D levels and bone formation markers

International Journal of Dermatology

Volumn 55, Issue 4, 2016, Pages e176-e183

  Bogaczewicz, Jaroslaw ^a   Karczmarewicz, Elzbieta ^b   Pludowski, Pawel ^b   Zabek, Jakub ^c   Wozniacka, Anna ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^c INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BIOLOGICAL MARKER; COLLAGEN; OSTEOCALCIN; PROCOLLAGEN TYPE I N TERMINAL PROPEPTIDE; SUNSCREEN; UNCLASSIFIED DRUG; VITAMIN D; 25-HYDROXYVITAMIN D; PEPTIDE FRAGMENT; PROCOLLAGEN; PROCOLLAGEN TYPE I N-TERMINAL PEPTIDE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; LEISURE; MALE; MOLECULAR DYNAMICS; POLAND; PROTEIN DETERMINATION; PROTEIN FUNCTION; SEASONAL VARIATION; SUN EXPOSURE; SYSTEMIC LUPUS ERYTHEMATOSUS; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; YOUNG ADULT; ANALOGS AND DERIVATIVES; BLOOD; DIETARY SUPPLEMENT; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; NORMAL HUMAN; SEASON; SUNLIGHT;

ADULT; AGED; DIETARY SUPPLEMENTS; FEMALE; HEALTHY VOLUNTEERS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; OSTEOCALCIN; PEPTIDE FRAGMENTS; POLAND; PROCOLLAGEN; SEASONS; SUNLIGHT; SUNSCREENING AGENTS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84960399698     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/ijd.13024     Document Type: Article

References (42)

1. Agbai ON, Buster K, Sanchez M, et al. Skin cancer and photoprotection in people of color: a review and recommendations for physicians and the public. J Am Acad Dermatol 2014; 70: 748-762.
2. Ting WW, Vest CD, Sontheimer R. Practical and experimental consideration of sun protection in dermatology. Int J Dermatol 2003; 42: 505-513.
3. Lehmann P, Schwarz T. Photodermatoses: diagnosis and treatment. Dtsch Arztebl Int 2011; 108: 135-141.
4. Matsuoka LY, Ide L, Wortsman J, et al. Sunscreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987; 64: 1165-1168.
5. Holick MF, MacLaughlin JA, Clark MB, et al. Photosynthesis of previtamin D3 in human skin and the physiologic consequences. Science 1980; 210: 203-205.
6. Karczmarewicz E, Czekuc-Kryskiewicz E, Płudowski P. Effect of vitamin D status on pharmacological treatment efficiency: Impact on cost-effective management in medicine. Dermatoendocrinology 2013; 5: 299-304.
7. Rosen CJ, Gallagher JC. The 2011 IOM report on vitamin D and calcium requirements for North America: clinical implications for providers treating patients with low bone mineral density. J Clin Densitom 2011; 14: 79-84.
8. Bogaczewicz J, Sysa-Jedrzejowska A, Arkuszewska C, et al. Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus 2012; 21: 477-484.
9. Smith EL, Walworth NC, Holick MF. Effect of 1 alpha, 25-dihydroxyvitamin D3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes grown in serum-free conditions. J Invest Dermatol 1986; 86: 709-714.
10. Rigby WF. The immunobiology of vitamin D. Immunol Today 1988; 9: 54-58.
11. Samochocki Z, Bogaczewicz J, Jeziorkowska R, et al. Vitamin D effects in atopic dermatitis. J Am Acad Dermatol 2013; 69: 238-244.
12. Krzyścin JW, Jarosławski J, Rajewska-Wiech B, et al. Space-based estimation of the solar UV-B doses for psoriasis heliotherapy in Poland using OMI data for the period 2005-2011. J Photochem Photobiol, B 2012; 117: 240-246.
13. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
14. Lam GK, Petri M. Assessment of systemic lupus erythematosus. Clin Exp Rheumatol 2005; 5(Suppl. 39): 120-132.
15. Carter GD, Carter CR, Gunter E, et al. Measurement of Vitamin D metabolites: an international perspective on methodology and clinical interpretation. J Steroid Biochem Mol Biol 2004; 89-90: 467-471.
16. Carvalho JF, Blank M, Kiss E, et al. Anti-vitamin D, vitamin D in SLE: preliminary results. Ann N Y Acad Sci 2007; 1109: 550-557.
17. Crofton PM, Evans N, Taylor MR, et al. Procollagen type I amino-terminal propeptide: pediatric reference data and relationship with procollagen type I carboxyl-terminal propeptide. Clin Chem 2004; 50: 2173-2176.
18. Mavroeidi A, O'Neill F, Lee PA, et al. Seasonal 25-hydroxyvitamin D changes in British postmenopausal women at 57 degrees N and 51 degrees N: a longitudinal study. J Steroid Biochem Mol Biol 2010; 121: 459-461.
19. Moan J, Dahlback A, Lagunova Z, et al. Solar radiation, vitamin D and cancer incidence and mortality in Norway. Anticancer Res 2009; 29: 3501-3509.
20. Hanwell HE, Vieth R, Cole DE, et al. Sun exposure questionnaire predicts circulating 25-hydroxyvitamin D concentrations in Caucasian hospital workers in southern Italy. J Steroid Biochem Mol Biol 2010; 121: 334-337.
21. Quesada-Gómez JM, Diaz-Curiel M, Sosa-Henriquez M, et al. Low calcium intake and inadequate vitamin D status in postmenopausal osteoporotic women. J Steroid Biochem Mol Biol 2013; 136: 175-177.
22. Hilger J, Friedel A, Herr R, et al. A systematic review of vitamin D status in populations worldwide. Br J Nutr 2014; 111: 23-45.
23. Johnson LK, Hofsø D, Aasheim ET, et al. Impact of gender on vitamin D deficiency in morbidly obese patients: a cross-sectional study. Eur J Clin Nutr 2012; 66: 83-90.
24. Seibel MJ. Biochemical markers of bone turnover. Part I: biochemistry and variability. Clin Biochem Rev 2005; 26: 97-122.
25. Seibel MJ. Biochemical markers of bone turnover. Part II: clinical applications in the management of osteoporosis. Clin Biochem Rev 2006; 27: 123-138.
26. Vasikaran S, Cooper C, Eastell R, et al. International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine position on bone marker standards in osteoporosis. Clin Chem Lab Med 2011; 49: 1271-1274.
27. Armas LA, Dowell S, Akhter M, et al. Ultraviolet-B radiation increases serum 25-hydroxyvitamin D levels: the effect of UVB dose and skin color. J Am Acad Dermatol 2007; 57: 588-593.
28. Basile LA, Taylor SN, Wagner CL, et al. Neonatal vitamin D status at birth at latitude 32 degrees 72′: evidence of deficiency. J Perinatol 2007; 27: 568-571.
29. Ganmaa D, Holick MF, Rich-Edwards JW, et al. Vitamin D deficiency in reproductive age Mongolian women: a cross sectional study. J Steroid Biochem Mol Biol 2014; 139: 1-6.
30. Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690-693.
31. Matsuoka LY, Wortsman J, Dannenberg MJ, et al. Clothing prevents ultraviolet-B radiation-dependent photosynthesis of vitamin D3. J Clin Endocrinol Metab 1992; 75: 1099-1103.
32. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985; 76: 1536-1538.
33. Pludowski P, Jaworski M, Niemirska A, et al. Vitamin D status, body composition and hypertensive target organ damage in primary hypertension. J Steroid Biochem Mol Biol 2014; 144: 180-184.
34. Botella-Carretero JI, Alvarez-Blasco F, Villafruela JJ, et al. Vitamin D deficiency is associated with the metabolic syndrome in morbid obesity. Clin Nutr 2007; 26: 573-580.
35. Auwerx J, Bouillon R, Kesteloot H. Relation between 25-hydroxyvitamin D3, apolipoprotein A-I, and high density lipoprotein cholesterol. Arterioscler Thromb 1992; 12: 671-674.
36. Chiu KC, Chu A, Go VL, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820-825.
37. 3 and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001; 86: 1633-1637.
38. 3 is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002; 110: 229-238.
39. Cigolini M, Iagulli MP, Miconi V, et al. Serum 25-hydroxyvitamin D3 concentrations and prevalence of cardiovascular disease among type 2 diabetic patients. Diabetes Care 2006; 29: 722-724.
40. Kaufmann M, Gallagher JC, Peacock M, et al. Clinical utility of simultaneous quantitation of 25-hydroxyvitamin D and 24, 25-dihydroxyvitamin D by LC-MS/MS involving derivatization with DMEQ-TAD. J Clin Endocrinol Metab 2014; 99: 2567-2574.
41. Carter GD. Accuracy of 25-hydroxyvitamin D assays: confronting the issues. Curr Drug Targets 2011; 12: 19-28.
42. Yetley EA, Pfeiffer CM, Schleicher RL, et al. NHANES monitoring of serum 25-hydroxyvitamin D: a roundtable summary. J Nutr 2010; 140: 2030-2045.